There are 1076 resources available
231P - CT image-based artificial intelligence quantification of intratumoral heterogeneity for predicting treatment response to immunotherapy combined with anti-angiogenic drugs in hepatocellular carcinoma
Presenter: Zhi-Cheng Jin
Session: Poster Display session
Resources:
Abstract
232P - Selective internal radiation therapy with Yttrium-90 (Y-90) resin microspheres for unresectable hepatocellular carcinoma: Experience of a single center in China
Presenter: Xiaobin Feng
Session: Poster Display session
Resources:
Abstract
233P - Association of circulating inflammatory marker ISG15 with clinical factors and survival in patients with liver cancer
Presenter: Winnie Yeo
Session: Poster Display session
Resources:
Abstract
234P - Mechanism of acinetobacter baumannii promoting gastric cancer metastasis by enhancing NAD metabolism
Presenter: Yan Yang
Session: Poster Display session
Resources:
Abstract
235P - Combined atezolizumab and bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma: A single center experience
Presenter: Abdallah Khalil
Session: Poster Display session
Resources:
Abstract
236P - Characteristics and prognosis of primary and acquired resistance to immune checkpoint inhibitors combination treatment in unresectable hepatocellular carcinoma
Presenter: Xiangqi Chen
Session: Poster Display session
Resources:
Abstract
237P - Radiotherapy with or without Immune checkpoint inhibitors and tyrosine kinase inhibitors in hepatocellular carcinoma with severe macrovascular invasion: A retrospective cohort study
Presenter: Qian-qian Tang
Session: Poster Display session
Resources:
Abstract
238P - Intestinal microbiota in locally advanced skin melanoma, gastric cancer and esophageal squamous cell carcinoma patients
Presenter: Angelina Kuzmenko
Session: Poster Display session
Resources:
Abstract
239P - Adjuvant TACE combined with tislelizumab in patients with resected hepatocellular carcinoma at high risk of recurrence: An open-label, multicenter, phase II trial
Presenter: Tao Ma
Session: Poster Display session
Resources:
Abstract
240P - Efficacy and safety of transarterial chemoembolization (TACE) in combination with tislelizumab and TKIs versus TACE for the treatment of Intermediate and advanced HCC: A retrospective cohort study
Presenter: Yue Han
Session: Poster Display session
Resources:
Abstract